Myo-Inositol Effects on Pregnancy Outcomes and Fetal Growth

International Journal of Medical Sciences and Pharma Research 2026 Open access

Read full text
Authors: Mukesh Kumar, Harpreet Singh, Tauhid Iqbali, Ravi Shah
DOI: 10.22270/ijmspr.v12i1.170
Cited by: 0
References: 13

Abstract

Myo-inositol (MI), a naturally occurring carbocyclic sugar and second messenger in insulin signaling, has emerged as a supplement of interest in pregnancy due to its potential metabolic and reproductive effects. This review summarizes current evidence on MI supplementation during pregnancy, with special emphasis on maternal outcomes (e.g., gestational diabetes mellitus [GDM], hypertensive disorders), neonatal outcomes like preterm birth, birthweight, and implications for fetal growth. Keywords: Myo-Inositol, GDM, Fetal growth, Diabetes

Fields of Study & Subjects

Gestational Diabetes Research and Management Pregnancy and preeclampsia studies Birth Development and Health

Publication details

Journal / source
International Journal of Medical Sciences and Pharma Research
Volume
12
Issue
1
Pages
11–13
Publication date
15 March 2026
Language
EN